ANDLAUER HEALTHCARE GROUP IN (AND.CA) Stock Fundamental Analysis
TSX:AND - Toronto Stock Exchange - CA0342231077 - Common Stock - Currency: CAD
We assign a fundamental rating of 6 out of 10 to AND. AND was compared to 17 industry peers in the Health Care Providers & Services industry. AND has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. AND is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AND was profitable.
In the past year AND had a positive cash flow from operations.
In the past 5 years AND has always been profitable.
In the past 5 years AND always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 10.08%, AND belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
AND has a better Return On Equity (16.20%) than 87.50% of its industry peers.
AND's Return On Invested Capital of 12.85% is amongst the best of the industry. AND outperforms 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.08% | ||
| ROE | 16.2% | ||
| ROIC | 12.85% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AND has a Profit Margin of 10.06%. This is amongst the best in the industry. AND outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of AND has remained more or less at the same level.
AND's Operating Margin of 14.63% is amongst the best of the industry. AND outperforms 93.75% of its industry peers.
AND's Operating Margin has been stable in the last couple of years.
The Gross Margin of AND (37.51%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AND has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.63% | ||
| PM (TTM) | 10.06% | ||
| GM | 37.51% |
OM growth 3Y-2.9%
OM growth 5Y0.08%
PM growth 3Y-5.24%
PM growth 5Y1.15%
GM growth 3Y-5.38%
GM growth 5Y-3.14%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AND is still creating some value.
There is no outstanding debt for AND. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 5.29 indicates that AND is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.29, AND belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
The Debt to FCF ratio of AND is 1.54, which is an excellent value as it means it would take AND, only 1.54 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AND (1.54) is better than 93.75% of its industry peers.
AND has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.25, AND belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 1.54 | ||
| Altman-Z | 5.29 |
ROIC/WACC1.69
WACC7.62%
2.3 Liquidity
AND has a Current Ratio of 1.44. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AND (1.44) is better than 87.50% of its industry peers.
AND has a Quick Ratio of 1.39. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.39, AND belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.39 |
3. Growth
3.1 Past
The earnings per share for AND have decreased by 0.00% in the last year.
The Earnings Per Share has been decreasing by -6.19% on average over the past years.
The Revenue has been growing slightly by 1.02% in the past year.
Measured over the past years, AND shows a quite strong growth in Revenue. The Revenue has been growing by 18.53% on average per year.
EPS 1Y (TTM)0%
EPS 3Y16.76%
EPS 5Y-6.19%
EPS Q2Q%13.89%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y27.27%
Revenue growth 5Y18.53%
Sales Q2Q%1.82%
3.2 Future
The Earnings Per Share is expected to grow by 10.56% on average over the next years. This is quite good.
Based on estimates for the next years, AND will show a small growth in Revenue. The Revenue will grow by 3.85% on average per year.
EPS Next Y3.27%
EPS Next 2Y9.15%
EPS Next 3Y10.56%
EPS Next 5YN/A
Revenue Next Year1.38%
Revenue Next 2Y3.45%
Revenue Next 3Y3.85%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 28.73 indicates a quite expensive valuation of AND.
Compared to the rest of the industry, the Price/Earnings ratio of AND indicates a rather cheap valuation: AND is cheaper than 87.50% of the companies listed in the same industry.
AND's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.62.
AND is valuated rather expensively with a Price/Forward Earnings ratio of 24.42.
AND's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AND is cheaper than 75.00% of the companies in the same industry.
AND's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.73 | ||
| Fwd PE | 24.42 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AND indicates a somewhat cheap valuation: AND is cheaper than 62.50% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AND is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.28 | ||
| EV/EBITDA | 11.48 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AND has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)8.8
PEG (5Y)N/A
EPS Next 2Y9.15%
EPS Next 3Y10.56%
5. Dividend
5.1 Amount
With a yearly dividend of 0.97%, AND is not a good candidate for dividend investing.
AND's Dividend Yield is a higher than the industry average which is at 3.87.
With a Dividend Yield of 0.97, AND pays less dividend than the S&P500 average, which is at 2.27.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.97% |
5.2 History
AND has been paying a dividend for over 5 years, so it has already some track record.
The dividend of AND decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
24.64% of the earnings are spent on dividend by AND. This is a low number and sustainable payout ratio.
DP24.64%
EPS Next 2Y9.15%
EPS Next 3Y10.56%
TSX:AND (2/21/2025, 7:00:00 PM)
45.39
+0.16 (+0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners67.26%
Inst Owner ChangeN/A
Ins Owners1.77%
Ins Owner ChangeN/A
Market Cap1.78B
Analysts74
Price Target49.64 (9.36%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.97% |
Yearly Dividend0.26
Dividend Growth(5Y)N/A
DP24.64%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.47%
Min EPS beat(2)-5.94%
Max EPS beat(2)-0.99%
EPS beat(4)1
Avg EPS beat(4)-6.11%
Min EPS beat(4)-21.24%
Max EPS beat(4)3.72%
EPS beat(8)2
Avg EPS beat(8)-5.83%
EPS beat(12)5
Avg EPS beat(12)18.98%
EPS beat(16)8
Avg EPS beat(16)17.19%
Revenue beat(2)0
Avg Revenue beat(2)-2.55%
Min Revenue beat(2)-3.14%
Max Revenue beat(2)-1.97%
Revenue beat(4)1
Avg Revenue beat(4)-2.38%
Min Revenue beat(4)-5.58%
Max Revenue beat(4)1.17%
Revenue beat(8)3
Avg Revenue beat(8)-1.87%
Revenue beat(12)7
Avg Revenue beat(12)1.62%
Revenue beat(16)9
Avg Revenue beat(16)1.08%
PT rev (1m)2.46%
PT rev (3m)3.18%
EPS NQ rev (1m)-0.86%
EPS NQ rev (3m)-4.96%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)-0.42%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-2.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.73 | ||
| Fwd PE | 24.42 | ||
| P/S | 2.74 | ||
| P/FCF | 17.28 | ||
| P/OCF | 14.03 | ||
| P/B | 4.41 | ||
| P/tB | 22.54 | ||
| EV/EBITDA | 11.48 |
EPS(TTM)1.58
EY3.48%
EPS(NY)1.86
Fwd EY4.09%
FCF(TTM)2.63
FCFY5.79%
OCF(TTM)3.23
OCFY7.13%
SpS16.59
BVpS10.3
TBVpS2.01
PEG (NY)8.8
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.08% | ||
| ROE | 16.2% | ||
| ROCE | 17.55% | ||
| ROIC | 12.85% | ||
| ROICexc | 13.77% | ||
| ROICexgc | 38.43% | ||
| OM | 14.63% | ||
| PM (TTM) | 10.06% | ||
| GM | 37.51% | ||
| FCFM | 15.83% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.9%
OM growth 5Y0.08%
PM growth 3Y-5.24%
PM growth 5Y1.15%
GM growth 3Y-5.38%
GM growth 5Y-3.14%
F-Score6
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 1.54 | ||
| Debt/EBITDA | 0.6 | ||
| Cap/Depr | 33.72% | ||
| Cap/Sales | 3.66% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.52% | ||
| Profit Quality | 157.44% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.39 | ||
| Altman-Z | 5.29 |
F-Score6
WACC7.62%
ROIC/WACC1.69
Cap/Depr(3y)34.52%
Cap/Depr(5y)29.4%
Cap/Sales(3y)3.49%
Cap/Sales(5y)2.86%
Profit Quality(3y)115.01%
Profit Quality(5y)129.98%
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y16.76%
EPS 5Y-6.19%
EPS Q2Q%13.89%
EPS Next Y3.27%
EPS Next 2Y9.15%
EPS Next 3Y10.56%
EPS Next 5YN/A
Revenue 1Y (TTM)1.02%
Revenue growth 3Y27.27%
Revenue growth 5Y18.53%
Sales Q2Q%1.82%
Revenue Next Year1.38%
Revenue Next 2Y3.45%
Revenue Next 3Y3.85%
Revenue Next 5YN/A
EBIT growth 1Y-0.94%
EBIT growth 3Y23.58%
EBIT growth 5Y18.62%
EBIT Next Year77.92%
EBIT Next 3Y25.63%
EBIT Next 5YN/A
FCF growth 1Y-5.26%
FCF growth 3Y20.05%
FCF growth 5Y9.64%
OCF growth 1Y-1.39%
OCF growth 3Y26.98%
OCF growth 5Y14.81%